Chemodex

Genistein

CHF 81.00
In stock
CDX-G0210-M02525 mgCHF 81.00
CDX-G0210-M100100 mgCHF 244.00
More Information
Product Details
Synonyms CI-75610; NSC 36586; Baichanin A; Differenol A; 4',5,7-Trihydroxyisoflavone; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
Product Type Chemical
Properties
Formula

C15H10O5

MW 270.24
CAS 446-72-0
RTECS NR2392000
Source/Host Chemicals Plant
Purity Chemicals ≥98% (HPLC)
Appearance Off-white to yellow powder.
Solubility Soluble in DMSO (30mg/ml). Slightly soluble in ethanol. Insoluble in water.
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key TZBJGXHYKVUXJN-UHFFFAOYSA-N
Smiles OC1=C2C(OC=C(C3=CC=C(O)C=C3)C2=O)=CC(O)=C1
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Genistein is an isoflavonoid phytoestrogen that has been found in soybeans and has kinase inhibitory, anticancer, pro-cancer and hepatoprotective properties. It is a cell-permeable, reversible, substrate competitive tyrosine kinase inhibitor (including EGFR phosphorylation), implicated in almost all cell growth and proliferation signal cascades. Genistein inhibits proliferation and induces cell cycle arrest and apoptosis in a variety of cancer cells. It is antiangiogenic agent, down-regulates the transcription of genes involved in controlling angiogenesis. On a molecular level it also inhibits mammalian DNA topoisomerase II and DNA methyltransferase, and binds to estrogen receptor β. Genistein has also antidiabetic, anti-inflammatory, antimicrobial and antioxidant properties. It is an α-glucosidase inhibitor, PPAR activator, GLUT4-mediated glucose uptake inhibitor, MALT1 inhibitor and acts as an agonist at the GPR30 receptor.

Product References

(1) T. Akiyama, et al.; J. Biol. Chem. 262, 5592 (1987) | (2) J. Markovits, et al.; Cancer Res. 49, 5111 (1989) | (3) G. Peterson & S. Barnes; BBRC 179, 661 (1991) | (4) DS. Lee & SH. Lee; FEBS Lett. 501, 84 (2001) | (5) P.K. Kar, et al.; Parasitol. Int. 51, 249 (2002) | (6) O. Mezei, et al.; J. Nutr. 133, 1238 (2003) | (7) Z.C. Dang, et al.; J. Biol. Chem. 278, 962 (2003) | (8) M. Bazuine, et al.; BBRC 326, 511 (2005) | (9) Y.H. Ju, et al.; Carcinogenesis 27, 1292 (2006) | (10) RM. Han, et al.; J. Agric. Food Chem. 57, 3780 (2009) | (11) Z.C. Dang; Obes. Rev. 10, 342 (2009) (Review) | (12) L.J. Luo, et al.; Arch. Biochem. Biophys. 522, 9 (2012) | (13) L. Fontan, et al.; Cancer Cell 22, 812 (2012) | (14) V. Singh, et al.; Curr. Cancer Drug Targets 13, 379 (2013) | (15) SY. Wang, et al.; Phytother. Res. 28, 1071 (2014) | (16) C. Spagnuolo, et al.; Adv. Nutr. 6, 408 (2015)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.